HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmavite Moves Into OTCs With Uqora Acquisition To Expand Women’s Health Lineup

Startup Uqora Finds Buyer Four Years After Launch

Executive Summary

Pharmavite acquires Uqora, a startup marketing supplements, OTCs and devices to prevent or treat urinary tract infections. Moving into the category adds a growth driver as UTIs are the most common bacterial infection requiring medical care in the US.

You may also be interested in...

Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line

“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.

Pharmavite's Nurish by Nature Made Subscription Line Extends With Active, Nutrition, Relax Packs

Pharmavite introduces curated, pre-bundled Nurish by Nature Made vitamin lifestyle packs – Active, Relax and Nutrition – containing multivitamins as well as three or four vitamins making each pack unique.

Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal

Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts